Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2–Seropositive Individuals

We analyzed 221 coronavirus disease 2019 cases identified between June 2020 and January 2021 in 6074 individuals screened for immunoglobulin G antibodies in May 2020, representing 77% of residents of 5 Italian municipalities. The relative risk of developing symptomatic infection in seropositive part...

Descripción completa

Detalles Bibliográficos
Autores principales: Manica, Mattia, Pancheri, Serena, Poletti, Piero, Giovanazzi, Giulia, Guzzetta, Giorgio, Trentini, Filippo, Marziano, Valentina, Ajelli, Marco, Grazia Zuccali, Maria, Benetollo, Pier Paolo, Merler, Stefano, Ferro, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406865/
https://www.ncbi.nlm.nih.gov/pubmed/34134145
http://dx.doi.org/10.1093/cid/ciab556
Descripción
Sumario:We analyzed 221 coronavirus disease 2019 cases identified between June 2020 and January 2021 in 6074 individuals screened for immunoglobulin G antibodies in May 2020, representing 77% of residents of 5 Italian municipalities. The relative risk of developing symptomatic infection in seropositive participants was 0.055 (95% confidence interval, .014–.220).

Ejemplares similares